Target intelligence / Profile preview

Hydroxycarboxylic acid receptor 3 (HCA3) (HCA3)

Target
HCA3
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Hydroxycarboxylic acid receptor 3 (HCA3), also known as GPR109B, is a G protein-coupled receptor that is evolutionarily unique to humans and great apes [1, 2]. It is primarily expressed in adipocytes and various immune cells, including neutrophils and macrophages [1, 3]. HCA3 serves as a sensor for metabolic intermediates such as 3-hydroxyoctanoic acid and the bacterial metabolite D-phenyllactic acid, which is produced by lactic acid bacteria found in fermented foods [2]. Upon activation, HCA3 couples with Gi proteins to inhibit adenylyl cyclase, thereby reducing intracellular cAMP levels and modulating functions like lipolysis and immune cell chemotaxis [3, 4]. In the context of disease, HCA3 is involved in regulating inflammatory responses and has been investigated for its role in metabolic disorders and certain cancers [2, 3]. While niacin is a known exogenous ligand, its therapeutic utility is often limited by its higher affinity for the closely related HCA2 receptor, which mediates the characteristic flushing side effect [4].

Other names
HCAR3GPR109BHM74G protein-coupled receptor 109BNiacin receptor 2
02

Mechanism of action

Agonism of the HCA3 receptor activates Gi-type G proteins, leading to the inhibition of adenylyl cyclase activity and a subsequent decrease in intracellular cyclic AMP (cAMP) levels [3, 4].

03

Biological functions

Signal transductionImmune responseLipid metabolism regulationChemotaxisInhibition of lipolysis
04

Disease associations

InflammationMetabolic disorderCancer
05

Safety considerations

Potential for off-target effects in immune modulationVasodilation and flushing (if cross-reacting with HCA2)
06

Interacting drugs

Niacin

2 more in the full profile.

07

Biomarkers

HCA3 expression levelsIntracellular cAMP levelsD-phenyllactic acid concentration

Beyond the preview

Go deeper on Hydroxycarboxylic acid receptor 3 (HCA3) (HCA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxycarboxylic acid receptor 3 (HCA3) (HCA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call